Arnold L Oronsky's Net Worth
Estimate Recalculated Nov 4, 2024 02:33AM EST
Who is Arnold L Oronsky
Arnold L Oronsky has an estimated net worth of $4.1 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics, Inc., Transcept Pharmaceuticals Inc, EPOCRATES INC, METABASIS THERAPEUTICS INC, AVEDRO INC, DYNAVAX TECHNOLOGIES CORP, CORGENTECH INC, PMV Pharmaceuticals, Inc., MACROGENICS INC, TESARO, Inc., APPLIED GENETIC TECHNOLOGIES CORP, MYOGEN INC, and CORIXA CORP.
SEC CIK
Arnold L Oronsky's CIK is 0001207833
Past Insider Trading and Trends
2005 was Arnold L Oronsky's most active year for acquiring shares with 9 total transactions. Arnold L Oronsky's most active month to acquire stocks was the month of May. 2005 was Arnold L Oronsky's most active year for disposing of shares, totalling 13 transactions. Arnold L Oronsky's most active month to dispose stocks was the month of June. 2011 saw Arnold L Oronsky paying a total of $400,000.00 for 199,008 shares, this is the most they've acquired in one year. In 2005 Arnold L Oronsky cashed out on 130,624 shares for a total of $274,533.60, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
